| Issue |
Title |
File |
| Vol 21, No 1 (2026) |
Evolution of non-invasive treatment of SMA: achievements of the first five years and new horizons |
(Rus)
|
|
Editorial T.
|
| Vol 21, No 1 (2026) |
Resolution of the Expert Council “Open questions in the management of patients with neuronal ceroid lipofuscinosis type 2” |
(Rus)
|
|
Editorial T.
|
| Vol 21, No 1 (2026) |
Non-medical switching of antiepileptic drugs in epilepsy: clinical risks and consensus recommendations for their minimization. Resolution of the Central Federal District Board of Experts in Neurology and Epileptology (March 28, 2026) |
(Rus)
|
|
Editorial T.
|
| Vol 20, No 3 (2025) |
Opening new horizons in clinical practice of non-invasive pathogenetic therapy of SMA 5q |
(Rus)
|
|
Editorial T.
|
| Vol 19, No 4 (2024) |
Scientific and practical conference “Absence epilepsy” |
(Rus)
|
|
Editorial a.
|
| Vol 19, No 2 (2024) |
The path from theory to practice in the diagnosis and treatment of patients with spinal muscular atrophy |
(Rus)
|
|
Editorial a.
|
| Vol 19, No 2 (2024) |
Spinal muscular atrophy is more than a movement disorder |
(Rus)
|
|
Editorial a.
|
| Vol 18, No 1 (2023) |
Neurofibromatosis type 1 and its complication – plexiform neurofibromas |
(Rus)
|
|
Editorial a.
|
| Vol 9, No 1 (2014) |
Совещание экспертов «Современные подходы к критериям выбора фармакотерапии эпилепсии в детском возрасте» |
(Rus)
|
|
Golubev A.M.
|
| 1 - 9 of 9 Items |
|
